HomeDMAAU • NASDAQ
add
Drugs Made In America Acquisition Units
Previous close
$10.48
Year range
$10.00 - $10.70
Market cap
345.90M USD
Avg Volume
1.42K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 131.92K | 140.15% |
Net income | 2.29M | 4,266.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 822.00 | -95.46% |
Total assets | 235.21M | 123,008.89% |
Total liabilities | 242.36M | 114,768.95% |
Total equity | -7.15M | — |
Shares outstanding | 33.52M | — |
Price to book | -49.90 | — |
Return on assets | -0.14% | — |
Return on capital | 4.62% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.29M | 4,266.28% |
Cash from operations | -106.66K | 7.20% |
Cash from investing | 0.00 | — |
Cash from financing | 106.55K | -19.90% |
Net change in cash | -101.00 | -100.56% |
Free cash flow | -46.29K | — |
About
Founded
2024
Website
